BMRN

BioMarin Pharmaceutical Inc. $66.41 1M -3.1% 3M +18.7% YTD +11.7% as of 2026-09-14
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.4%
Next 1 month
-0.5%
Seasonality
No real seasonal tilt
Next 30 days (to Oct 15): +0.3% median, 50% of the last 26 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 88
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.09%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.43 -0.2% · Seasonal tilt -0.3%
$12.7B market cap (#754 US) $118M/day volume 35% volatility +19% 1-year -56% from ATH
52-week range · 79% of the way up · -6% from the high
$49.26$70.98

Congressional trades in BMRN Full tracker →

8 members · 10 buys / 11 sells · $34K–$307K disclosed · latest filing Apr 17, 2023.

SELL DG Daniel Goldman · traded Mar 6, 2023 $1K–$15K
SELL JG Josh Gottheimer · traded Oct 18, 2021 $1K–$15K
BUY GC Gilbert Cisneros · traded Dec 30, 2020 $15K–$50K
BUY JG Josh Gottheimer · traded Oct 16, 2020 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2020 $1K–$15K
BUY JG Josh Gottheimer · traded Dec 16, 2019 $1K–$15K
BUY JG Josh Gottheimer · traded Dec 11, 2019 $1K–$15K
SELL AL Alan S. Lowenthal · traded Aug 14, 2019 $1K–$15K

Earnings Full history →

Next report 2026-10-26 (Monday, after close, in 41 days) · EPS est. 1.34.

1-day std dev
3.8%
Finished up
48%
Biggest pop
+9.0%
Biggest drop
-9.9%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.